These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35371012)

  • 1. Comprehensive Metabolic Profiling of Inflammation Indicated Key Roles of Glycerophospholipid and Arginine Metabolism in Coronary Artery Disease.
    Zhu Q; Wu Y; Mai J; Guo G; Meng J; Fang X; Chen X; Liu C; Zhong S
    Front Immunol; 2022; 13():829425. PubMed ID: 35371012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression.
    Chen H; Wang Z; Qin M; Zhang B; Lin L; Ma Q; Liu C; Chen X; Li H; Lai W; Zhong S
    Front Mol Biosci; 2021; 8():632950. PubMed ID: 33937325
    [No Abstract]   [Full Text] [Related]  

  • 3. Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    Fan Y; Li Y; Chen Y; Zhao YJ; Liu LW; Li J; Wang SL; Alolga RN; Yin Y; Wang XM; Zhao DS; Shen JH; Meng FQ; Zhou X; Xu H; He GP; Lai MD; Li P; Zhu W; Qi LW
    J Am Coll Cardiol; 2016 Sep; 68(12):1281-93. PubMed ID: 27634119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
    Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine metabolome profiling of immune-mediated inflammatory diseases.
    Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
    BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40-65: a prospective cross-sectional study.
    Zhang CY; Xu RQ; Wang XQ; Sun LF; Mo P; Cai RJ; Lin XZ; Luo CF; Ou WC; Lu LJ; Zhong Y; Chen JY
    Cardiovasc Diabetol; 2023 Aug; 22(1):219. PubMed ID: 37620823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
    Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the metabolic divide: distinctive metabolites differentiating CAD-T2DM from CAD patients.
    Liu Y; Liu JE; He H; Qin M; Lei H; Meng J; Liu C; Chen X; Luo W; Zhong S
    Cardiovasc Diabetol; 2024 Jan; 23(1):14. PubMed ID: 38184583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals.
    Pietzner M; Kaul A; Henning AK; Kastenmüller G; Artati A; Lerch MM; Adamski J; Nauck M; Friedrich N
    BMC Med; 2017 Nov; 15(1):210. PubMed ID: 29187192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach.
    Basak T; Varshney S; Hamid Z; Ghosh S; Seth S; Sengupta S
    J Proteomics; 2015 Sep; 127(Pt A):169-77. PubMed ID: 25790721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic-Metabolomic Associations Support the Role of
    Lains I; Zhu S; Han X; Chung W; Yuan Q; Kelly RS; Gil JQ; Katz R; Nigalye A; Kim IK; Miller JB; Carreira IM; Silva R; Vavvas DG; Miller JW; Lasky-Su J; Liang L; Husain D
    Ophthalmol Sci; 2021 Mar; 1(1):. PubMed ID: 34382031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics Profiling of Stages of Coronary Artery Disease Progression.
    Anlar GG; Anwardeen N; Al Ashmar S; Pedersen S; Elrayess MA; Zeidan A
    Metabolites; 2024 May; 14(6):. PubMed ID: 38921428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity.
    Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J
    Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics profiling and pathway analysis of human plasma and urine reveal further insights into the multifactorial nature of coronary artery disease.
    Amin AM; Mostafa H; Arif NH; Abdul Kader MAS; Kah Hay Y
    Clin Chim Acta; 2019 Jun; 493():112-122. PubMed ID: 30826371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma metabolomics provides new insights into the relationship between metabolites and outcomes and left ventricular remodeling of coronary artery disease.
    Zhu Q; Qin M; Wang Z; Wu Y; Chen X; Liu C; Ma Q; Liu Y; Lai W; Chen H; Cai J; Liu Y; Lei F; Zhang B; Zhang S; He G; Li H; Zhang M; Zheng H; Chen J; Huang M; Zhong S
    Cell Biosci; 2022 Oct; 12(1):173. PubMed ID: 36242008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between neutrophils to HDL-C ratio and severity of coronary stenosis.
    Kou T; Luo H; Yin L
    BMC Cardiovasc Disord; 2021 Mar; 21(1):127. PubMed ID: 33676400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying metabolomic profiles of inflammatory diets in postmenopausal women.
    Tabung FK; Liang L; Huang T; Balasubramanian R; Zhao Y; Chandler PD; Manson JE; Cespedes Feliciano EM; Hayden KM; Van Horn L; Clish CB; Giovannucci EL; Rexrode KM
    Clin Nutr; 2020 May; 39(5):1478-1490. PubMed ID: 31255351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired metabolism predicts coronary artery calcification in women with systemic lupus erythematosus.
    Urbain F; Ponnaiah M; Ichou F; Lhomme M; Materne C; Galier S; Haroche J; Frisdal E; Mathian A; Durand H; Pha M; Hie M; Kontush A; Cluzel P; Lesnik P; Amoura Z; Guerin M; Cohen Aubart F; Le Goff W
    EBioMedicine; 2023 Oct; 96():104802. PubMed ID: 37725854
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.